妇产科在线APP下载
- 课程目录
- 专家简介
- 课程简介
- 评论
-
SEUD Online Week Introduction & Hologic : Minimally invasive gynaecology and COVID - Opening and Plenary session #1: Endometriosis
- Keynote lecture #1: Endometriosis, a complex systemic disease
- Plenary session #2: Abnormal uterine bleedings
- Plenary session #3: Uterine fibroids
- Plenary session #4: Adenomyosis
- Keynote lecture #2: Fertility preservation in women with endometriosis
- Vifor: PBM strategies to improve outcomes in gynecology and obstetrics
- Myovant: New perspectives in uterine fibroids
- Gedeon Richter: A pragmatic approach to the management of uterine fibroids
- Obseva: The power of the GnRH antagonist MoA to personalize fibroid management
- Bayer: The pandemic as catalyst of the paradigm shift in gynecological therapy
- Abbvie: Breaking the silence around uterine fibroid
Obseva: The power of the GnRH antagonist MoA to personalize fibroid management
Introduction – The E2 theory and Linzagolix: a new oral GnRH antagonist, Felice Petraglia (Italy)
Heavy menstrual bleeding due to uterine fibroids: Lingazolix efficacy and safety, Hugh Taylor (USA)
Hormonal add-back therapy in the treatment of uterine fibroids, Jacques Donnez (Belgium)
评论文章
京公网安备 11010202008857号
